Payer+Provider's Health System Review
CRNA expanded scope of practice stirs debate in West Virginia House
FDA calls for warning labels on commercial CAR-T therapies amid cancer probe
January 23, 2024
Ongoing economic struggles have forced ASCs to update their strategy — or in some cases, face potential closure.
Read the full post on Becker's ASC